Phase 4 Ankylosing Spondylitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and have signed a consent form agreeing to participate.
- You are between 18 and 59 years old.
- You have been diagnosed with spinal arthritis (also called spondyloarthritis) using recognised medical guidelines — either affecting the spine/pelvis or the joints in other parts of the body.
- Your spinal arthritis is currently in an active phase, meaning a specific blood and symptom score (ASDAS-CRP) shows your condition is active enough to qualify (confirm with trial site).
Who may not be able to join:
- You have certain other health conditions, including throat/nasal infections, active tuberculosis, inflammatory bowel disease, other rheumatic or immune system diseases, cancer, or other bone and joint diseases.
- You are known to be allergic to any ingredients in the study drug being tested.
- Your liver or kidney function test results are significantly abnormal — specifically, certain liver enzyme or kidney levels that are more than twice the normal range.
- You are pregnant, trying to become pregnant, or currently breastfeeding.
- You have moderate to severe heart failure (a serious level of heart weakness, confirmed by a doctor's grading system).
- You have an active stomach or intestinal ulcer, or are experiencing gastrointestinal bleeding.
- You currently show signs of a streptococcal infection (such as severe sore throat, tonsillitis, scarlet fever, or a skin infection caused by streptococcal bacteria), with abnormal related blood test results.
- The trial researchers decide for any other reason that the study drug or the trial is not suitable for you.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0086-20-18665000156
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient ASAS40 remission rate after 12 weeks of patient medication
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.